QUICK SEARCH

Select Category
Text Search
articles per page.
WHAT ELSE?

How can you help?
Resources
F.A.Q
Links
join our mailing list

Would you like to be notified, whenever there is a new publication online? Join our mailing list to get the latest updates!

E-mail



You are visitor no: 85672
© Edna Kyrie. All rights reserved.

Welcome to Thyroidresearch.com!

The aim of the site is to put extracts from thyroid-related medical research online and to trace the development of diagnosis and treatment. Patients will find it useful for an in depth exploration of their conditions. Doctors and medical students will discover a wealth of information, much of it previously not available except from specialist libraries with restricted access. Medical historians will be saved long trips to libraries and can obtain articles dating back more than a century.

There are 2771 articles online!


5 RECENTLY ADDED PUBLICATIONS


Chronic fatigue syndrome and mitochondrial dysfunction

Author Sarah Myhill1, , Norman E. Booth2,, John McLaren-Howard3
Publication Int J Clin Exp Med (2009) 2, 1-16 www.ijcem.com/IJCEM812001
Date published 9.1.2015

...


Thyroid-stimulating hormone assessments in a Dutch cohort of 620 men with lifelong premature ejaculation without erectile dysfunction.

Author Waldinger MD, Zwinderman AH, Olivier B, Schweitzer DH
Publication J Sex Med. 2005 Nov;2(6):865-70.
Date published 20.11.2002

INTRODUCTION: Apart from the involvement of central serotonergic neurotransmission on lifelong premature ejaculation, interference of thyroid function has been speculated. AIM: To study thyroid function in a large group of men with lifelong premature ejaculation (LPE). METHODS: Lifelong premature ejaculation was defined as an intravaginal ejaculation latency time (IELT) of less than 1 minute. Any consecutive man with LPE and no erectile dysfunction assessed by medical history and the Internation...


Sexual Function and Obstructive Sleep Apnea-Hypopnea: A Randomized Clinical Trial Evaluating the Effects of Oral-Appliance and Continuous Positive Airway Pressure Therapy.

Author Hoekema A, Stel AL, Stegenga B, van der Hoeven JH, Wijkstra PJ, van Driel MF, de Bont LG
Publication J Sex Med. 2006 Nov 1; [Epub ahead of print]
Date published 20.11.2001

Introduction. The obstructive sleep apnea-hypopnea syndrome (OSAHS) is associated with sexual dysfunction. Although successful treatment with continuous positive airway pressure (CPAP) has been demonstrated to improve sexual function, the effects of oral-appliance therapy are unknown. Aim. The aims of this study were to determine to what extent untreated male OSAHS patients experience sexual dysfunctions compared with control subjects, and second, to evaluate the effects of oral-appliance and CP...


Cardiovascular disease, metabolic syndrome and erectile dysfunction.

Author Muller A,, Mulhall JP
Publication Curr Opin Urol. 2006 Nov;16(6):435-43.
Date published 20.11.2016

PURPOSE OF REVIEW: Erectile dysfunction and cardiovascular disease share the same risk factors such as hypertension, diabetes, dyslipidemia, obesity, and smoking, all of which are implicated in causing endothelial dysfunction. In this review, an overview is given on the role of endothelium in the pathophysiology of erectile dysfunction, cardiovascular disease, and the metabolic syndrome as well as the links between them. RECENT FINDINGS: Current literature offers strong evidence that endothelial...


Erectile dysfunction and cardiac disease: recommendations of the Second Princeton Conference.

Author Rosen RC, Jackson G, Kostis JB
Publication Curr Urol Rep. 2006 Nov;7(6):490-6. Review.
Date published 20.11.2007

Erectile dysfunction (ED) has been linked increasingly to cardiovascular risk factors and comorbidities. Considering the potential risk associated with sexual activity, guidelines were developed (Princeton I) for assessment and management of patients with varying degrees of cardiac risk. These guidelines were recently updated (Princeton II) based on new data concerning the link between ED and cardiovascular disease and the availability of additional phosphodiesterase type 5 inhibitors (vardenafi...